Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Dir DP until

34.578 (0.229%)
NAV on April 17, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,229 cr
Turnover Ratio 11.18%
Expense Ratio 0.72%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 1.90%
  • 1Y: 3.11%
  • 3M: -0.71%
  • 3Y: 23.68%
  • 6M: -4.44%
  • 5Y: 15.10%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since over 1 year)
ISIN INF277K011B8
Fund Family Tata
P/E Ratio 38.31
P/B Ratio 5.88
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -0.23
Beta 0.97
R-Squared 93.92
Info Ratio -0.22
Tracking Err 4.18
Sortino 1.602
Sharpe 0.930
Std Dev 16.865
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.63%
Industrial 0.0%
Technology 0.0%
Basic Materials 5.05%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 94.33%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

This fund may declare and pay out a dividend to you on a periodic basis, but only when it has the profits to do so.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Quant
Quant Healthcare Fund Direct Growth
16.084 9.92% 327 cr 0.83% -
Mirae
Mirae Asset Healthcare Fund Direct Growth
44.015 9.47% 2,754 cr 0.51% -
Uti
UTI Healthcare Fund-Growth Option- Direct
324.116 7.55% 1,056 cr 1.29% -
Icici
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
42.020 7.00% 6,293 cr 1.04% -
Sbi
SBI Healthcare Opportunities Fund Direct Growth
496.821 5.26% 4,064 cr 0.92% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund